PMI
Picard Medical, Inc.
Healthcare — Medical Devices
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
None
$4.26
+$0.06 (+1.43%)
Price History
52-Week Range
Sign in to add PMI to a watchlist or set price alerts.
Fundamentals
| Market Cap | $17.68M |
| P/E Ratio (TTM) | - |
| Forward P/E | -1.91 |
| EPS (TTM) | $-0.76 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 85.50% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 39.3 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $13.68 |
| 52-Week Low | $0.11 |
| 50-Day Avg | $0.28 |
| 200-Day Avg | $2.55 |
| Avg Volume | $29.67M |
| Volume | $16.60M |
Performance Analysis
BULLISHPMI shows predominantly bullish signals based on its fundamentals and technicals.
~
Trading at 31% of its 52-week range.
~
RSI at 39.3 is in neutral territory.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
+
Strong revenue growth of 85.5% year-over-year.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:26 UTC
Back to Screener Export Report